AIMS: High-resolution melting (HRM) screening and scanning for single-nucleotide polymorphisms (SNPs) afford the advantages of a quicker, less expensive, and less demanding option compared to other methods for sequence analysis. The evaluation of large populations of patients for multiple SNPs in a high-throughput manner is the next phase in individualized medicine. RESULTS: We demonstrated that Tm profiles can be generated from gDNA samples that clearly differentiate homozygous ancestral, homozygous SNP, and heterozygous genotypes, while identifying samples of unique outcome without the cumbersome processes of normalization, temperature shifting, and difference plot generation. CONCLUSIONS: Through expanded primer selection criterion and inclusion of a cloning fragment length double-stranded DNA sequence-specific control template, we are now able to generate additional data via HRM melt domains that are greatly simplified, while considering both the peak melt temperature and profile.
AIMS: High-resolution melting (HRM) screening and scanning for single-nucleotide polymorphisms (SNPs) afford the advantages of a quicker, less expensive, and less demanding option compared to other methods for sequence analysis. The evaluation of large populations of patients for multiple SNPs in a high-throughput manner is the next phase in individualized medicine. RESULTS: We demonstrated that Tm profiles can be generated from gDNA samples that clearly differentiate homozygous ancestral, homozygous SNP, and heterozygous genotypes, while identifying samples of unique outcome without the cumbersome processes of normalization, temperature shifting, and difference plot generation. CONCLUSIONS: Through expanded primer selection criterion and inclusion of a cloning fragment length double-stranded DNA sequence-specific control template, we are now able to generate additional data via HRM melt domains that are greatly simplified, while considering both the peak melt temperature and profile.
Authors: Inmaculada de Juan; Eva Esteban; Sarai Palanca; Eva Barragán; Pascual Bolufer Journal: Breast Cancer Res Treat Date: 2008-06-05 Impact factor: 4.872
Authors: Michael Liew; Robert Pryor; Robert Palais; Cindy Meadows; Maria Erali; Elaine Lyon; Carl Wittwer Journal: Clin Chem Date: 2004-07 Impact factor: 8.327
Authors: Rossella Tricarico; Francesca Crucianelli; Antonio Alvau; Claudio Orlando; Roberta Sestini; Francesco Tonelli; Rosa Valanzano; Maurizio Genuardi Journal: BMC Cancer Date: 2011-07-21 Impact factor: 4.430
Authors: Jason B Nikas; Janet T Lee; Elizabeth D Maring; Jill Washechek-Aletto; Donna Felmlee-Devine; Ruth A Johnson; Thomas C Smyrk; Patrick S Tawadros; Lisa A Boardman; Clifford J Steer Journal: Am J Cancer Res Date: 2015-09-15 Impact factor: 6.166